Drug Biz Wants Strong IP Measures In Pacific Trade Pact

Law360, New York (March 4, 2013, 6:24 PM EST) -- A group representing pharmaceutical companies on Monday urged the countries participating in talks on an Asia-Pacific free trade pact to build strong intellectual property protections into the proposed deal.

The Pharmaceutical Research and Manufacturers of America, or PhRMA, said protecting intellectual property was key to maintaining the sort of innovation that has led to a host of treatments for diseases like Alzheimer's, cancer and diabetes. The group's vice president of international affairs, Jay Taylor, warned that inadequate IP protections in the Trans-Pacific Partnership could undermine that...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.